Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Burgner, D, Usen, S, Rockett, K, Jallow, M, Ackerman, H, Cervino, A, Pinder, M, Kwiatkowski, DP.
Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria.
Human Genetics
114(4)
:
401 -401
2004
view publication
Yee, LJ, Knapp, S, Burgner, D, Hennig, BJW, Frodsham, AJ, Wright, M, Thomas, HC, Hill, AVS, Thursz, MR.
525 Inducible nitric oxide (NOS2A) haplotypes and the clinical outcomes of hepatitis C virus infection.
Journal of Hepatology
40:
154 -155
2004
view publication
Jamieson, SE, Miller, EN, Black, GF, Peacock, CS, Cordell, HJ, Howson, JMM, Shaw, M-A, Burgner, D, Xu, W, Lins-Lainson, Z, et al.
Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians..
Genes Immun
5(1)
:
46 -57
2004
view publication
Davidson, N, Skull, S, Burgner, D, Kelly, P, Raman, S, Silove, D, Steel, Z, Vora, R, Smith, M.
An issue of access: delivering equitable health care for newly arrived refugee children in Australia..
J Paediatr Child Health
40(9-10)
:
569 -575
2004
view publication
Davidson, N, Skull, S, Chaney, G, Frydenberg, A, Jones, C, Isaacs, D, Kelly, P, Lampropoulos, B, Raman, S, Silove, D, et al.
Comprehensive health assessment for newly arrived refugee children in Australia..
J Paediatr Child Health
40(9-10)
:
562 -568
2004
view publication